BeOne Medicines Ltd
282 hedge funds and large institutions have $10.3B invested in BeOne Medicines Ltd in 2026 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 112 increasing their positions, 85 reducing their positions, and 37 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 85
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
3.19% more ownership
Funds ownership: 28.55% → 31.73% (+3.2%)
1% more capital invested
Capital invested by funds: $10.3B → $10.3B (+$74.8M)
0% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 37
1% less funds holding
Funds holding: 286 → 282 (-4)
13% less call options, than puts
Call options by funds: $37M | Put options by funds: $42.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$525M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$161M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$85.2M |
| 4 |
Millennium Management
New York
|
+$56.1M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$42.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$309M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$270M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$96.8M |
| 4 |
JG
Jain Global
New York
|
-$31M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$28.8M |
ONC Hedge Fund Activity: Q1 2026 in Review
282 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2026, worth a combined $10.3B — up 0.73% from $10.3B a quarter earlier.
Fund positioning in ONC was balanced in Q1 2026: 37 funds opened new positions, 37 closed out, 112 added to existing stakes and 85 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $525M. The largest seller was Capital International Investors, cutting an estimated $309M.
- 282 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2026, down from 286 in Q4 2025.
- Funds reported $10.3B of BeOne Medicines Ltd stock for Q1 2026, up 0.73% quarter-over-quarter.
- 37 funds opened new BeOne Medicines Ltd positions in Q1 2026 and 37 closed out, a net change of 0 holders.
- The largest BeOne Medicines Ltd buyer in Q1 2026 was Capital World Investors, an estimated $525M added.
- The largest BeOne Medicines Ltd seller in Q1 2026 was Capital International Investors, an estimated $309M sold.
Based on aggregated 13F filings for Q1 2026.